Page last updated: 2024-09-03

marimastat and Arthritis

marimastat has been researched along with Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiodo, TA; Dickson, R; Hawkins, MJ; Johnson, M; Marshall, J; Ness, E; Rasmussen, HS; Sale, M; Steen, V; Torri, J; Wojtowicz-Praga, S	1

Trials

1 trial(s) available for marimastat and Arthritis

Article	Year
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6 Topics: Administration, Oral; Aged; Arthritis; Collagenases; Enzyme Inhibitors; Female; Gelatinases; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Middle Aged; Treatment Outcome	1998

Article

Year

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6

Topics: Administration, Oral; Aged; Arthritis; Collagenases; Enzyme Inhibitors; Female; Gelatinases; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Middle Aged; Treatment Outcome

1998